nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers
|
Madorsky-Feldman, Dana |
|
2016 |
157 |
2 |
p. 319-327 |
artikel |
2 |
A novel subtype classification and risk of breast cancer by histone modification profiling
|
Chen, Xiaohua |
|
2016 |
157 |
2 |
p. 267-279 |
artikel |
3 |
Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
|
Belum, Viswanath Reddy |
|
2016 |
157 |
2 |
p. 395-400 |
artikel |
4 |
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
|
Jacot, William |
|
2016 |
157 |
2 |
p. 307-318 |
artikel |
5 |
Erratum: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)
|
Shapiro, Alice C. |
|
2016 |
157 |
2 |
p. 403 |
artikel |
6 |
Erratum to: The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom
|
Schmidt, Nina |
|
2016 |
157 |
2 |
p. 401 |
artikel |
7 |
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling
|
Gelsomino, Luca |
|
2016 |
157 |
2 |
p. 253-265 |
artikel |
8 |
Germline RECQL mutations in high risk Chinese breast cancer patients
|
Kwong, Ava |
|
2016 |
157 |
2 |
p. 211-215 |
artikel |
9 |
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
|
Bustreo, Sara |
|
2016 |
157 |
2 |
p. 363-371 |
artikel |
10 |
Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance
|
Inoue, Kenichi |
|
2016 |
157 |
2 |
p. 295-305 |
artikel |
11 |
Plasma S100P level as a novel prognostic marker of metastatic breast cancer
|
Peng, Cike |
|
2016 |
157 |
2 |
p. 329-338 |
artikel |
12 |
Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer
|
Huo, Jinhai |
|
2016 |
157 |
2 |
p. 373-383 |
artikel |
13 |
Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells
|
Wise, Randi |
|
2016 |
157 |
2 |
p. 241-252 |
artikel |
14 |
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy
|
Villarreal-Garza, Cynthia |
|
2016 |
157 |
2 |
p. 385-394 |
artikel |
15 |
Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1
|
Speyer, Cecilia L. |
|
2016 |
157 |
2 |
p. 217-228 |
artikel |
16 |
Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy
|
Molinaro, Annette M. |
|
2016 |
157 |
2 |
p. 351-361 |
artikel |
17 |
Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer
|
Rosenstock, Aron S. |
|
2016 |
157 |
2 |
p. 339-350 |
artikel |
18 |
The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema
|
Sun, Fangdi |
|
2016 |
157 |
2 |
p. 229-240 |
artikel |
19 |
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies
|
Karakatsanis, Andreas |
|
2016 |
157 |
2 |
p. 281-294 |
artikel |
20 |
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy
|
Sulaica, Elisabeth |
|
2016 |
157 |
2 |
p. 203-210 |
artikel |